Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis

This publication has 45 references indexed in Scilit:

• Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
  PLOS ONE, 2012
• Apolipoprotein M - a new biomarker in sepsis
  Critical Care, 2012
• Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes
  Critical Care, 2012
• Early potassium channel blockade improves sepsis‐induced organ damage and cardiovascular dysfunction
  British Journal of Pharmacology, 2011
• Group V Phospholipase A2 Mediates Barrier Disruption of Human Pulmonary Endothelial Cells Caused by LPS In Vitro
  American Journal of Respiratory Cell and Molecular Biology, 2011
• Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
  PLOS ONE, 2011
• Regulation of Fasting Fuel Metabolism by Toll-Like Receptor 4
  Diabetes, 2010
• Bench-to-bedside review: Glucose and stress conditions in the intensive care unit
  Critical Care, 2010
• Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase
  Life Sciences, 2009
• Immunodesign of experimental sepsis by cecal ligation and puncture
  Nature Protocols, 2008